Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(02): 275-280
DOI: 10.1055/s-0042-1760328
Review Article

Imaging Recommendations for Diagnosis, Staging, and Management of Testicular Cancer

Aparna Katdare
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Palak Popat
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Rachel Sequeira
3   Department of Radiodiagnosis, Mangalore Institute of Oncology, Mangalore, Karnataka, India
,
Nilesh Sable
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Kunal Gala 
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Daksh Chandra 
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Archi Agrawal
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Gagan Prakash 
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Vedang Murthy
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Santosh Menon 
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Amit Joshi
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Ajaykumar Singh
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
,
Suyash Kulkarni
1   Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, Maharashtra, India
2   Homi Bhabha National Institute, Mumbai, Maharashtra, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

The common testicular tumors affect young males in the third and fourth decades and germ cell tumors especially have excellent post-treatment outcomes. Hence, guidelines for clinical, radiological, and tumor marker assessment for diagnosis, response assessment, and surveillance of these tumors have critical impact on the management of these tumors. This article aims to discuss the current recommendations and guidelines regarding the clinical and radiological assessment and treatment pathways of testicular tumors.

Keywords

guidelines - imaging - recommendations - testicular cancer


Publication History

Article published online:
04 May 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 [World Cancer Research Fund. Worldwide Cancer Data: Global cancer statistics for the most common cancers. Accessed December 9, 2022, at: https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data] .
  • 2 Znaor A, Lortet-Tieulent J, Jemal A, Bray F. International variations and trends in testicular cancer incidence and mortality. Eur Urol 2014; 65 (06) 1095-1106
    CrossrefPubMedGoogle Scholar
  • 3 Williamson SR, Delahunt B, Magi-Galluzzi C. et al; Members of the ISUP Testicular Tumour Panel. The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel. Histopathology 2017; 70 (03) 335-346
    CrossrefPubMedGoogle Scholar
  • 4 Mittal PK, Abdalla AS, Chatterjee A. et al. Spectrum of extratesticular and testicular pathologic conditions at scrotal MR imaging. Radiographics 2018; 38 (03) 806-830
    CrossrefPubMedGoogle Scholar
  • 5 Makovník M, Rejleková K, Uhrin I, Mego M, Chovanec M. Intricacies of radiographic assessment in testicular germ cell tumors. Front Oncol 2021; 10: 587523 https://www.frontiersin.org/article/10.3389/fonc.2020.587523
    CrossrefPubMedGoogle Scholar
  • 6 Looijenga LHJ, Van der Kwast TH, Grignon D. et al. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: current and future utilization of molecular-genetic tests for testicular germ cell tumors. Am J Surg Pathol 2020; 44 (07) e66-e79
    CrossrefPubMedGoogle Scholar
  • 7 Oosterhuis JW, Looijenga LHJ. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005; 5 (03) 210-222
    CrossrefPubMedGoogle Scholar
  • 8 Hale GR, Teplitsky S, Truong H, Gold SA, Bloom JB, Agarwal PK. Lymph node imaging in testicular cancer. Transl Androl Urol 2018; 7 (05) 864-874
    CrossrefPubMedGoogle Scholar
  • 9 Magers MJ, Idrees MT. Updates in staging and reporting of testicular cancer. Surg Pathol Clin 2018; 11 (04) 813-824
    CrossrefPubMedGoogle Scholar
  • 10 International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15 (02) 594-603
    CrossrefPubMedGoogle Scholar
  • 11 Laguna M. et al. EAU guidelines on testicular cancer 2022. Accessed December 9, 2022, at : http://www.uroweb.org/guideline/testicularcancer/
  • 12 Lobo J, Leão R, Gillis AJM. et al. Utility of Serum miR-371a-3p in predicting relapse on surveillance in patients with clinical stage I testicular germ cell cancer. Eur Urol Oncol 2021; 4 (03) 483-491
    CrossrefPubMedGoogle Scholar
  • 13 Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles?. AJR Am J Roentgenol 2009; 193 (01) 55-60
    CrossrefPubMedGoogle Scholar
  • 14 Coursey Moreno C, Small WC, Camacho JC. et al. Testicular tumors: what radiologists need to know–differential diagnosis, staging, and management. Radiographics 2015; 35 (02) 400-415
    CrossrefPubMedGoogle Scholar
  • 15 Winter TC, Kim B, Lowrance WT, Middleton WD. Testicular microlithiasis: what should you recommend?. AJR Am J Roentgenol 2016; 206 (06) 1164-1169
    CrossrefPubMedGoogle Scholar
  • 16 Lock G, Schmidt C, Helmich F, Stolle E, Dieckmann KP. Early experience with contrast-enhanced ultrasound in the diagnosis of testicular masses: a feasibility study. Urology 2011; 77 (05) 1049-1053
    CrossrefPubMedGoogle Scholar
  • 17 Aigner F, De Zordo T, Pallwein-Prettner L. et al. Real-time sonoelastography for the evaluation of testicular lesions. Radiology 2012; 263 (02) 584-589
    CrossrefPubMedGoogle Scholar
  • 18 Feldman DR, Lorch A, Kramar A. et al. Brain metastases in patients with germ cell tumors: Prognostic factors and treatment options - an analysis from the Global Germ Cell Cancer Group. J Clin Oncol 2016; 34 (04) 345-351
    CrossrefPubMedGoogle Scholar
  • 19 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Testicular Cancer. Version 1.2019. October 22, 2018. Accessed December 9, 2022, at : https://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf
  • 20 Necchi A, Nicolai N, Alessi A. et al. Interim 18F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions. In: Clinical Genitourinary Cancer. Vol 14.; 2016. DOI: 10.1016/j.clgc.2015.08.010
    Crossref
  • 21 Honecker F, Aparicio J, Berney D. et al. ESMO consensus conference on testicular germ cell cancer: diagnosis, treatment and follow-up. In: Annals of Oncology. Vol 29.; 2018. DOI: 10.1093/annonc/mdy217
    Crossref
  • 22 Bachner M, Loriot Y, Gross-Goupil M. et al. 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial. Ann Oncol 2012; 23 (01) 59-64
    CrossrefPubMedGoogle Scholar
  • 23 Cathomas R, Klingbiel D, Bernard B. et al. Questioning the value of fluorodeoxyglucose positron emission tomography for residual lesions after chemotherapy for metastatic seminoma: results of an International Global Germ Cell Cancer Group Registry. J Clin Oncol 2018; 36 (34) JCO1800210 DOI: 10.1200/JCO.18.00210.
    CrossrefPubMedGoogle Scholar
  • 24 Murthy V, Karmakar S, Carlton J. et al. Radiotherapy for post-chemotherapy residual mass in advanced seminoma: a fluorodeoxyglucose positron emission tomography-computed tomography-based risk-adapted approach. Clin Oncol (R Coll Radiol) 2021; 33 (07) e315-e321
    CrossrefPubMedGoogle Scholar
  • 25 Oechsle K, Hartmann M, Brenner W. et al; German Multicenter Positron Emission Tomography Study Group. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol 2008; 26 (36) 5930-5935
    CrossrefPubMedGoogle Scholar
  • 26 Ilic D, Misso ML. Screening for testicular cancer. Cochrane Database Syst Rev 2011; (02) CD007853
    PubMedGoogle Scholar
  • 27 Gilbert K, Nangia AK, Dupree JM, Smith JF, Mehta A. Fertility preservation for men with testicular cancer: is sperm cryopreservation cost effective in the era of assisted reproductive technology?. Urol Oncol 2018; 36 (03) 92.e1-92 .e9
    CrossrefPubMedGoogle Scholar
  • 28 Brierley JE. et al. The TNM Classification of Malignant Tumours 8th edition. 2016. Accessed December 9, 2022, at: https://www.uicc.org/resources/tnm-classification-malignant-tumours-8th-edition